Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers
Clinical trial NCT05245838 · COMPLETED
Trial details
- NCT number
- NCT05245838
- Sponsor
- Dynavax Technologies Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-10
- Primary completion
- 2022-10-20
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.